These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8711933)

  • 1. p53 protein expression in extrahepatic bile duct cancer.
    Lee YC; Song SY; Chung JB; Kang JK; Park IS
    Yonsei Med J; 1996 Apr; 37(2):112-7. PubMed ID: 8711933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the expression of p53, MIB-1 (Ki-67 antigen), and argyrophilic nucleolar organizer regions in carcinoma of the extrahepatic bile duct.
    Suto T; Sugai T; Nakamura S; Funato O; Nitta H; Sasaki R; Kanno S; Saito K
    Cancer; 1998 Jan; 82(1):86-95. PubMed ID: 9428483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 protein immunoreactivity in cancers of the gallbladder, extrahepatic bile ducts and ampulla of Vater.
    Lee CS; Pirdas A
    Pathology; 1995 Apr; 27(2):117-20. PubMed ID: 7567135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods in pathology. p53 expression in formalin-fixed, paraffin-embedded archival specimens of intrahepatic cholangiocarcinoma: retrieval of p53 antigenicity by microwave oven heating of tissue sections.
    Terada T; Shimizu K; Izumi R; Nakanuma Y
    Mod Pathol; 1994 Feb; 7(2):249-52. PubMed ID: 8008749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An immunohistochemical study of p53 protein in gallbladder and extrahepatic bile duct/ampullary carcinomas.
    Teh M; Wee A; Raju GC
    Cancer; 1994 Sep; 74(5):1542-5. PubMed ID: 7520348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and clinical significance of cell cycle regulatory proteins in gallbladder and extrahepatic bile duct cancer.
    Kim WB; Han HJ; Lee HJ; Park SS; Song TJ; Kim HK; Suh SO; Kim YC; Choi SY
    Ann Surg Oncol; 2009 Jan; 16(1):23-34. PubMed ID: 18979138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 expression as a prognostic determinant in resected distal bile duct carcinoma.
    Rijken AM; Offerhaus GJ; Polak MM; Gouma DJ; van Gulik TM
    Eur J Surg Oncol; 1999 Jun; 25(3):297-301. PubMed ID: 10336811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive papillary carcinomas of the extrahepatic bile ducts: a clinicopathologic and immunohistochemical study of 13 cases.
    Hoang MP; Murakata LA; Katabi N; Henson DE; Albores-Saavedra J
    Mod Pathol; 2002 Dec; 15(12):1251-8. PubMed ID: 12481004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of Ki-67 and p53 antigen expression in carcinomas of bile duct and gallbladder.
    Shrestha ML; Miyake H; Kikutsuji T; Tashiro S
    J Med Invest; 1998 Aug; 45(1-4):95-102. PubMed ID: 9864969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic determinants in extrahepatic bile duct cancer.
    Kurosaki I; Tsukada K; Watanabe H; Hatakeyama K
    Hepatogastroenterology; 1998; 45(22):905-9. PubMed ID: 9755978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical study of DPC4 and p53 proteins in gallbladder and bile duct cancers.
    Chuang SC; Lee KT; Tsai KB; Sheen PC; Nagai E; Mizumoto K; Tanaka M
    World J Surg; 2004 Oct; 28(10):995-1000. PubMed ID: 15573254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical detection of proliferating cell nuclear antigen and p53 expression in carcinoma of the extrahepatic bile duct.
    Suto T; Sugai T; Nakamura S; Uesugi N; Sasaki R; Kanno S; Saito K
    Oncology; 1997; 54(5):407-13. PubMed ID: 9260603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of basement membrane type IV collagen α2 and α6 chains as a prognostic factor in patients with extrahepatic bile duct carcinoma.
    Hirashima K; Iyama K; Baba Y; Honda Y; Sado Y; Ninomiya Y; Watanabe M; Takamori H; Beppu T; Baba H
    J Surg Oncol; 2013 Mar; 107(4):402-7. PubMed ID: 22927259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and clinical significance of the G1-S modulators in carcinoma of the extrahepatic bile duct.
    Ito Y; Takeda T; Sakon M; Monden M; Tsujimoto M; Matsuura N
    Anticancer Res; 2000; 20(1A):337-44. PubMed ID: 10769677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of cell cycle-related molecules in biliary premalignant lesions: biliary intraepithelial neoplasia and biliary intraductal papillary neoplasm.
    Nakanishi Y; Zen Y; Kondo S; Itoh T; Itatsu K; Nakanuma Y
    Hum Pathol; 2008 Aug; 39(8):1153-61. PubMed ID: 18495210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and clinical implications of bcl-2 in extrahepatic bile duct carcinoma: its relationship with biological features.
    Ito Y; Takeda T; Sakon M; Tsujimoto M; Matsuura N
    Anticancer Res; 2000; 20(5C):3891-5. PubMed ID: 11268472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of retinoblastoma protein and p16INK4 protein expression in extrahepatic bile duct carcinomas.
    Cui X; Hui AM; Li X; Shi YZ; Takayama T; Hatakeyama K; Makuuchi M
    Hepatogastroenterology; 2000; 47(35):1216-20. PubMed ID: 11100316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of extrahepatic bile duct carcinomas according to the New American Joint Committee on Cancer staging system focused on tumor classification problems in 222 patients.
    Hong SM; Kim MJ; Pi DY; Jo D; Cho HJ; Yu E; Ro JY
    Cancer; 2005 Aug; 104(4):802-10. PubMed ID: 15959914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of CD44 variant 6 expression in advanced extrahepatic bile duct/ampullary carcinoma.
    Yokoyama Y; Hiyama E; Murakami Y; Matsuura Y; Yokoyama T
    Cancer; 1999 Nov; 86(9):1691-9. PubMed ID: 10547541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of p53 in adenocarcinoma of the gallbladder and bile ducts.
    Washington K; Gottfried MR
    Liver; 1996 Apr; 16(2):99-104. PubMed ID: 8740842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.